Prodotti correlati : stem cells research
-
-
-
-
-
Rituximab biosimilar–Research Grade
Rituximab biosimilar is a chimeric monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with CD20.CD0-M36 428.00 EUR -
-
-
-
-
